Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors.
Saved in:
| Title: | Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. |
|---|---|
| Authors: | Goebel L; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Kirschner T; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Koska S; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Rai A; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Janning P; Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Maffini S; Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Vatheuer H; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Czodrowski P; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Goody RS; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany., Müller MP; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany., Rauh D; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany. |
| Source: | ELife [Elife] 2023 Mar 27; Vol. 12. Date of Electronic Publication: 2023 Mar 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36972177 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Goebel+L%22">Goebel L</searchLink>; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Kirschner+T%22">Kirschner T</searchLink>; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Koska+S%22">Koska S</searchLink>; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Rai+A%22">Rai A</searchLink>; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Janning+P%22">Janning P</searchLink>; Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Maffini+S%22">Maffini S</searchLink>; Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Vatheuer+H%22">Vatheuer H</searchLink>; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Czodrowski+P%22">Czodrowski P</searchLink>; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Goody+RS%22">Goody RS</searchLink>; Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+MP%22">Müller MP</searchLink>; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.<br /><searchLink fieldCode="AU" term="%22Rauh+D%22">Rauh D</searchLink>; Department of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2023 Mar 27; Vol. 12. <i>Date of Electronic Publication: </i>2023 Mar 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36972177 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.82184 Languages: – Code: eng Text: English Titles: – TitleFull: Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Goebel L – PersonEntity: Name: NameFull: Kirschner T – PersonEntity: Name: NameFull: Koska S – PersonEntity: Name: NameFull: Rai A – PersonEntity: Name: NameFull: Janning P – PersonEntity: Name: NameFull: Maffini S – PersonEntity: Name: NameFull: Vatheuer H – PersonEntity: Name: NameFull: Czodrowski P – PersonEntity: Name: NameFull: Goody RS – PersonEntity: Name: NameFull: Müller MP – PersonEntity: Name: NameFull: Rauh D IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 03 Text: 2023 Mar 27 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 12 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |
